Eleven Biotherapeutics (EBIO) Appoints Gary Sternberg, M.D., M.B.A., As Executive Vice President Corporate And Business Development
5/5/2014 7:15:25 AM
Eleven Biotherapeutics (NASDAQ:EBIO), a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today announced the appointment of Gary J. Sternberg, M.D., M.B.A. as Executive Vice President of Corporate and Business Development. Dr. Sternberg brings more than 20 years of ophthalmology expertise including biotechnology and pharmaceutical industry experience and medical practice.
Help employers find you! Check out all the jobs and post your resume.
comments powered by